| Typicality: | 0.412 |
| Saliency: | 0.345 |
| in the next few years | 6 | temporal |
| for neuroblastoma | 2 | transitive-object |
| drug → be in → the pipeline | 33 |
| drug → come through → the pipeline | 4 |
| drug → come down → the pipeline | 3 |
| negative | neutral | positive |
| 0.145 | 0.658 | 0.197 |
| Raw frequency | 40 |
| Normalized frequency | 0.345 |
| Modifier score | 0.544 |
| Perplexity | 28.426 |